---
author:
  - name: Nicolas Langlitz
    url: 'https://aeon.co/users/nicolas-langlitz'
    avatar: {}
related: []
publisher:
  url: 'https://aeon.co'
  name: Aeon
  favicon: 'https://aeon.co/favicon.ico'
  domain: aeon.co
keywords:
  - psychedelic
  - drug
  - placebo-controlled
  - trials
  - psilocybin
  - heffter
  - settings
  - pharmacological
  - patients
  - researchers
description: 'Psychedelic research is back from underground laboratories to university hospitals. When LSD, mescaline and psilocybin were prohibited in 1970, all academic research on humans was abandoned for two decades. Now the return of psychedelic drugs to highly regarded research facilities, which began in the 1990s, is on the verge of reaching its goal.'
inLanguage: en
app_links: []
isBasedOnUrl: 'https://aeon.co/opinions/psychedelics-can-t-be-tested-using-conventional-clinical-trials'
title: "Psychedelics can't be tested using conventional clinical trials - Nicolas Langlitz - Aeon Opinions"
datePublished: '2016-03-19T16:38:54.905Z'
dateModified: '2016-03-19T16:34:53.317Z'
sourcePath: _posts/2016-03-19-psychedelics-cant-be-tested-using-conventional-clinical-tri.md
published: true
inFeed: true
hasPage: false
inNav: false
_context: 'http://schema.org'
_type: MediaObject

---
<article style=""><h1>Psychedelics can't be tested using conventional clinical trials - Nicolas Langlitz - Aeon Opinions</h1><p>Psychedelic research is back from underground laboratories to university hospitals. When LSD, mescaline and psilocybin were prohibited in 1970, all academic research on humans was abandoned for two decades. Now the return of psychedelic drugs to highly regarded research facilities, which began in the 1990s, is on the verge of reaching its goal.</p><img src="https://epsilon.aeon.co/images/ec9b2ea1-102a-48c6-ad9c-e96cdd6ff070/opinion_John-Shephard-6108086703_657fb33751_o.jpg" /></article>